Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V

10.3109/03009748909092614

10.1093/rheumatology/32.7.533

10.1046/j.1365-2567.1999.00772.x

10.2165/00063030-200115020-00001

10.1016/S0889-857X(05)70205-2

10.1093/rheumatology/40.2.205

10.1002/art.1780230202

10.1002/art.1780360601

10.1002/art.1780380107

Van Gestel AM, 1999, J Rheumatol, 26, 705

10.1002/art.10701

10.1136/ard.61.10.883

10.1002/1529-0131(200109)44:9<2029::AID-ART352>3.0.CO;2-2

10.1080/03009740310000346

Takemura S, 2001, J Immunol, 167, 4710, 10.4049/jimmunol.167.8.4710

10.1097/00002281-200305000-00011

Tighe H, Carson DA. Rheumatoid factors. In: Kelley WN, Harris ED Jr, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 5th ed. Vol. 1. Philadelphia: W.B. Saunders, 1997:241-9.

10.1136/ard.51.9.1029

10.1056/NEJM200103223441207

McLaughlin P, 1999, Semin Oncol, 26, 79